← Back to Search

RealConsent2.0 for Preventing Sexual Violence

N/A
Waitlist Available
Led By Laura Salazar, Ph.D.
Research Sponsored by Georgia State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Identify as a man or transgender man, age 21-25
Be between 18 and 65 years old
Must not have
Any medical or psychiatric condition, as well as current use of a medication, that would contraindicate alcohol administration
Physical disability: any physical disability that would prevent an individual from participating in the virtual reality task (self-report and determined)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at 12-months

Summary

This trial is testing the effects of alcohol on young men's ability to intervene in situations that could lead to sexual violence, as well as testing a web-based program designed to teach bystanders how to intervene when they see potential sexual violence.

Who is the study for?
This trial is for men aged 21-25 who have consumed alcohol in the past year. It's not suitable for those in a long-term relationship, with certain psychiatric or neurological disorders, significant hearing problems, severe asthma, legal restrictions against drinking, infrequent alcohol consumption, serious head injuries, over 250 pounds weight or seeking treatment for substance use.
What is being tested?
The study tests how alcohol affects young men's willingness to help prevent sexual violence and evaluates RealConsent2.0—a web-based program designed to promote helpful intervention by bystanders at risk situations when alcohol is involved—using VR scenarios and self-reports.
What are the potential side effects?
Since this trial involves interventions like stress management programs and virtual reality experiences rather than medical treatments or drugs, traditional side effects are not applicable. However, participants may experience discomfort from VR usage.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a man or transgender man aged between 21 and 25.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I don't have any health conditions or take medications that make it unsafe for me to consume alcohol.
Select...
I do not have a physical disability that stops me from using virtual reality.
Select...
I have been diagnosed with a neurological disorder.
Select...
I weigh more than 250 pounds.
Select...
I am experiencing significant psychological distress.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 6-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline at 6-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Bystander behavior
Self-Reported Bystander Behavior
Secondary study objectives
Barriers to Sexual Assault Bystander Intervention
Bystander Attitude Scale
Bystander Efficacy Scale
+2 more

Trial Design

6Treatment groups
Experimental Treatment
Active Control
Group I: RealConsent2.0 with PlaceboExperimental Treatment2 Interventions
Men assigned to complete a revised web-based multi-media sexual violence and bystander intervention prevention program. Men assigned to a no-alcohol placebo control arm.
Group II: RealConsent2.0 with AlcoholExperimental Treatment2 Interventions
Men assigned to complete a revised web-based multi-media sexual violence and bystander intervention prevention program. Men assigned to alcohol intoxication arm (target BrAC=.08).
Group III: Stress Management with AlcoholActive Control2 Interventions
Men assigned to complete a web-based stress management program. Men assigned to alcohol intoxication arm (target BrAC=.08).
Group IV: Stress Management with PlaceboActive Control2 Interventions
Men assigned to complete a web-based stress management program. Men assigned to a no-alcohol placebo control arm.
Group V: RealConsent 1.0 with PlaceboActive Control2 Interventions
Men assigned to complete a web-based multi-media sexual violence and bystander intervention prevention program. Men assigned to a no-alcohol placebo control arm.
Group VI: RealConsent 1.0 with AlcoholActive Control2 Interventions
Men assigned to complete a web-based multi-media sexual violence and bystander intervention prevention program. Men assigned to alcohol intoxication arm (target breath alcohol concentration (BrAC=.08).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Alcohol intoxication
2019
N/A
~360

Find a Location

Who is running the clinical trial?

Georgia State UniversityLead Sponsor
65 Previous Clinical Trials
30,039 Total Patients Enrolled
University of Nebraska LincolnOTHER
37 Previous Clinical Trials
12,223 Total Patients Enrolled
Laura Salazar, Ph.D.Principal InvestigatorGeorgia State University

Media Library

Alcohol intoxication Clinical Trial Eligibility Overview. Trial Name: NCT04912492 — N/A
Alcohol Intoxication Research Study Groups: Stress Management with Alcohol, Stress Management with Placebo, RealConsent2.0 with Alcohol, RealConsent 1.0 with Placebo, RealConsent2.0 with Placebo, RealConsent 1.0 with Alcohol
Alcohol Intoxication Clinical Trial 2023: Alcohol intoxication Highlights & Side Effects. Trial Name: NCT04912492 — N/A
Alcohol intoxication 2023 Treatment Timeline for Medical Study. Trial Name: NCT04912492 — N/A
~114 spots leftby Aug 2025